Voyageur Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 0.2
| VM Stock | CAD 0.20 0.01 5.26% |
Voyageur |
Voyageur Pharmaceuticals Target Price Odds to finish over 0.2
The tendency of Voyageur Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.20 | 90 days | 0.20 | about 58.48 |
Based on a normal probability distribution, the odds of Voyageur Pharmaceuticals to move above the current price in 90 days from now is about 58.48 (This Voyageur Pharmaceuticals probability density function shows the probability of Voyageur Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.48 . This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Voyageur Pharmaceuticals will likely underperform. Additionally Voyageur Pharmaceuticals has an alpha of 0.0492, implying that it can generate a 0.0492 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Voyageur Pharmaceuticals Price Density |
| Price |
Predictive Modules for Voyageur Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Voyageur Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Voyageur Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Voyageur Pharmaceuticals is not an exception. The market had few large corrections towards the Voyageur Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Voyageur Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Voyageur Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.05 | |
β | Beta against Dow Jones | 1.48 | |
σ | Overall volatility | 0.05 | |
Ir | Information ratio | 0.02 |
Voyageur Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Voyageur Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Voyageur Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Voyageur Pharmaceuticals is way too risky over 90 days horizon | |
| Voyageur Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Voyageur Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Voyageur Pharmaceuticals currently holds 2.15 M in liabilities with Debt to Equity (D/E) ratio of 28.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Voyageur Pharmaceuticals has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Voyageur Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Voyageur Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Voyageur Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Voyageur to invest in growth at high rates of return. When we think about Voyageur Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.71 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Voyageur Pharmaceuticals currently holds about 27.59 K in cash with (302.29 K) of positive cash flow from operations. | |
| Latest headline from news.google.com: Voyageur Pharmaceuticals Grants Deferred Share Units and Options and Accelerates Expiry Date of Warrants - TradingView |
Voyageur Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Voyageur Stock often depends not only on the future outlook of the current and potential Voyageur Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Voyageur Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 139.5 M | |
| Shares Float | 145.7 M |
Voyageur Pharmaceuticals Technical Analysis
Voyageur Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Voyageur Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Voyageur Pharmaceuticals. In general, you should focus on analyzing Voyageur Stock price patterns and their correlations with different microeconomic environments and drivers.
Voyageur Pharmaceuticals Predictive Forecast Models
Voyageur Pharmaceuticals' time-series forecasting models is one of many Voyageur Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Voyageur Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Voyageur Pharmaceuticals
Checking the ongoing alerts about Voyageur Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Voyageur Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Voyageur Pharmaceuticals is way too risky over 90 days horizon | |
| Voyageur Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Voyageur Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Voyageur Pharmaceuticals currently holds 2.15 M in liabilities with Debt to Equity (D/E) ratio of 28.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Voyageur Pharmaceuticals has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Voyageur Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Voyageur Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Voyageur Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Voyageur to invest in growth at high rates of return. When we think about Voyageur Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.71 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Voyageur Pharmaceuticals currently holds about 27.59 K in cash with (302.29 K) of positive cash flow from operations. | |
| Latest headline from news.google.com: Voyageur Pharmaceuticals Grants Deferred Share Units and Options and Accelerates Expiry Date of Warrants - TradingView |
Additional Tools for Voyageur Stock Analysis
When running Voyageur Pharmaceuticals' price analysis, check to measure Voyageur Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyageur Pharmaceuticals is operating at the current time. Most of Voyageur Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Voyageur Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyageur Pharmaceuticals' price. Additionally, you may evaluate how the addition of Voyageur Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.